Theriva™ Biologics raises $4 million through a warrant incentive operation, intended for working capital and general corporate purposes.
Amount Raised
$4 Million
Round Type
Funding Round
Investors
Description
Theriva™ Biologics announced a warrant incentive agreement with current institutional investors for the immediate exercise of warrants to raise approximately $4 million. The proceeds will be used to increase working capital and for general corporate purposes. The offer will remain open until additional gross proceeds up to $400,000 are achieved. The closing is expected around October 17, 2025, pending customary closing conditions.
Quick answer
Theriva Biologics raised $4 Million in a Funding Round round, dated October 16, 2025. Investors: A.G.P./Alliance Global Partners. Theriva Biologics is based in Rockville, Maryland, United States.
- How much did Theriva Biologics raise?
- Theriva Biologics raised $4 Million in a Funding Round round on October 16, 2025.
- Who invested in Theriva Biologics?
- A.G.P./Alliance Global Partners is named as investors in this round.
- What does Theriva Biologics do?
- Theriva Biologics, Inc. was formerly known as Synthetic Biologics, Inc. Theriva™ is a clinical-stage immuno-oncology company developing oncolytic viruses intended to overcome the protective barrier surrounding solid..
- Where is Theriva Biologics based and how big is it?
- Theriva Biologics is based in Rockville, Maryland, United States. Fundz records about 22 employees.
- Who are the decision-makers at Theriva Biologics?
- Fundz holds 2 contacts at Theriva Biologics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Therapeutics around the same time
Companies in the same sectors as Theriva Biologics that raised within 45 days of this round, from Fundz verified event records.
- BeyondSpring raised $2M (Funding Round) on November 21, 2025.
- GenSight Biologics raised $2.3M (Funding Round) on November 10, 2025.
- Acasti raised $4M (Funding Round) on October 23, 2025.
- Minerva Neurosciences raised $200M (Funding Round) on October 21, 2025.
- ISOThrive raised $8.1M on October 10, 2025.
- TORL BioTherapeutics raised $96M (Series C) on October 7, 2025.
Who to call at Theriva Biologics, and when
A new round usually means Theriva Biologics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Theriva Biologics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Theriva Biologics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Theriva Biologics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Theriva Biologics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Theriva Biologics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.